Biogen Reports Top-Line Results from Phase 2 Study of Opicinumab (Anti-LINGO-1) in Multiple Sclerosis
http://media.biogen.com/press-release/i ... anti-lingo
Biogen Opicinumab(Anti-LINGO-1) Fails Phase 2 Study of in MS
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 12442 Views
-
Last post by NHE
-
- 0 Replies
- 2367 Views
-
Last post by frodo
-
- 0 Replies
- 1414 Views
-
Last post by Petr75
-
- 0 Replies
- 10729 Views
-
Last post by NHE
-
- 0 Replies
- 1977 Views
-
Last post by NHE
-
- 0 Replies
- 2490 Views
-
Last post by frodo
-
- 0 Replies
- 1606 Views
-
Last post by frodo
-
- 0 Replies
- 1537 Views
-
Last post by frodo
-
- 0 Replies
- 1246 Views
-
Last post by frodo